Dr. Martens plc (LON:DOCS – Get Free Report) insider Giles Wilson acquired 207 shares of the company’s stock in a transaction that occurred on Tuesday, February 11th. The shares were acquired at an average cost of GBX 73 ($0.91) per share, for a total transaction of £151.11 ($188.09).
Giles Wilson also recently made the following trade(s):
- On Monday, January 13th, Giles Wilson bought 222 shares of Dr. Martens stock. The shares were bought at an average price of GBX 68 ($0.85) per share, for a total transaction of £150.96 ($187.90).
Dr. Martens Stock Up 1.0 %
Shares of LON DOCS opened at GBX 72.01 ($0.90) on Thursday. The company has a quick ratio of 1.13, a current ratio of 2.85 and a debt-to-equity ratio of 129.55. The firm has a 50-day moving average price of GBX 72.31 and a 200 day moving average price of GBX 65.58. Dr. Martens plc has a 52 week low of GBX 49.32 ($0.61) and a 52 week high of GBX 100 ($1.24). The stock has a market capitalization of £692.53 million, a price-to-earnings ratio of 1,028.71, a price-to-earnings-growth ratio of 6.40 and a beta of 0.11.
Dr. Martens Cuts Dividend
The firm also recently announced a dividend, which will be paid on Tuesday, April 8th. Shareholders of record on Thursday, March 6th will be given a dividend of GBX 0.85 ($0.01) per share. This represents a yield of 1.47%. The ex-dividend date is Thursday, March 6th. Dr. Martens’s payout ratio is currently 4,285.71%.
Dr. Martens Company Profile
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.
The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.
Read More
- Five stocks we like better than Dr. Martens
- Energy and Oil Stocks Explained
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Inflation Persists, But So Do Stock Opportunities: Rally On
- Are Penny Stocks a Good Fit for Your Portfolio?
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.